Kiromic BioPharma Inc. (KRBP)
0.18
-0.00 (-0.07%)
At close: Mar 24, 2025, 3:59 PM
-0.07% (1D)
| Bid | 0.16 |
| Market Cap | 477.94K |
| Revenue (ttm) | n/a |
| Net Income (ttm) | n/a |
| EPS (ttm) | -3.17 |
| PE Ratio (ttm) | -0.06 |
| Forward PE | -0.52 |
| Analyst | n/a |
| Ask | 0.21 |
| Volume | 42,934 |
| Avg. Volume (20D) | 7,709 |
| Open | 0.30 |
| Previous Close | 0.18 |
| Day's Range | 0.18 - 0.31 |
| 52-Week Range | 0.05 - 3.31 |
| Beta | 1.66 |
About KRBP
Kiromic BioPharma, Inc., an artificial intelligence driven allogeneic cell therapy company, engages in developing the multi-indication allogeneic T cell therapies that exploits the natural potency of the Gamma Delta T cell to target solid tumors. The company develops ALEXIS-ISO-1, an allogenic gamma delta CAR-T cell therapy product candidate targeting Isomesothelin; and ALEXIS-PRO-1, an allogeneic gamma delta chimeric T cell therapy product candi...
Industry Biotechnology
Sector Healthcare
IPO Date Oct 16, 2020
Employees 44
Stock Exchange NASDAQ
Ticker Symbol KRBP
Website https://www.kiromic.com
